• Heidi strengthens collaboration with Samsung Medical Center(SMC), South Korea’s premier smart hospital

• SMC to become Heidi's first partner in South Korea

• Development of a standardized AI service model optimized for the Korean healthcare environment expected through the partnership

Heidi Pty Ltd. (Heidi) a global healthcare AI company, announced that it signed a Memorandum of Understanding (MOU) with Samsung Medical Center (SMC). The MOU was signed by Thomas Kelly, Co-founder and CEO of Heidi and Seung Woo Park, President of SMC. Under the agreement, the two organizations will develop a Korean-ready version of the Heidi platform, with SMC serving as Heidi's flagship clinical partner in Korea and the first site where the platform is validated against Korean clinical, technical and regulatory requirements.

Founded in 2019 in Melbourne, Australia, Heidi currently supports more than 3 million patient consultations per week across 190 countries in 110 languages. Beyond its core ambient transcription capabilities, the company offers a range of AI-powered solutions tailored to clinical workflows, including specialty-specific documentation templates and real-time AI assistance to support clinical decision-making. These include Heidi Evidence, which gives clinicians access to trusted medical research at the point of care. Heidi's recent funding includes a US$100 million Series C led by Blackbird and a US$240 million growth investment from General Catalyst's Customer Value Fund.

Through this partnership, Heidi and SMC will explore opportunities to integrate Heidi's speech-to-text technology into DARWIN, with the aim of enhancing clinical documentation and supporting healthcare professionals in their daily workflows. Under the MOU, Heidi will deploy a proof of concept of Heidi’s on-premise solution within SMC's own infrastructure. The deployment will be integrated with the hospital's electronic medical record (EMR) system and built on HL7 FHIR, the global standard for exchanging health information. The two organizations will assess the platform on technical performance, physician acceptance and documentation quality, and will work together on a Korean Clinical Documentation Standard, a Korean FHIR Implementation Guide and a Heidi Korea Reference Architecture. 

Should the proof of concept succeed, SMC will serve as the reference site for future deployments of Heidi across Korean healthcare organizations. Heidi can be deployed on-premise or as a cloud service, giving hospitals the flexibility to choose the model that suits their infrastructure and data security requirements.

Heidi is also developing a range of AI agents for clinicians, moving the platform beyond documentation to supervised clinical action, supporting the work around patient visits. Both organizations plan to explore further opportunities to expand their collaboration across these areas.

"Samsung Medical Center represents Heidi's first collaboration in South Korea and will serve as a key partner as we expand into the Korean healthcare market," said Thomas Kelly, Co-founder and CEO of Heidi. "Korean clinicians are among the most skilled in the world, and they manage patient volumes few of their peers elsewhere would recognise. Every minute spent on documentation comes out of time with patients. Working with SMC lets us build Heidi around the way medicine is practised in Korea, from its documentation standards to the hospital systems clinicians use every day, so the time we give back goes to patient care."

“We expect this collaboration with Heidi to further accelerate our efforts to create a more patient-centered AI-powered healthcare environment,” said Professor Seung Woo Park, President and CEO of Samsung Medical Center (SMC). “This partnership will mark another important milestone for SMC as we continue to shape the future of smart hospitals by bringing the next generation of healthcare to life.”

SMC was recently ranked fourth globally and first in South Korea in Newsweek's World's Best Smart Hospitals 2027 rankings. The hospital has also achieved Stage 7, the highest level of certification awarded by the Healthcare Information and Management Systems Society (HIMSS), across four maturity models: Infrastructure Adoption Model (INFRAM), Electronic Medical Record Adoption Model (EMRAM), Digital Imaging Adoption Model (DIAM), and Adoption Model for Analytics Maturity (AMAM).

Notably, SMC became the first healthcare institution worldwide to achieve Stage 7 in INFRAM in 2022 and DIAM in 2023.